Covalon Technologies (OTCMKTS:CVALF – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02, Zacks reports. Covalon Technologies had a net margin of 3.08% and a return on equity of 3.31%.
Covalon Technologies Trading Up 3.9%
Shares of OTCMKTS:CVALF opened at $1.49 on Thursday. The firm has a fifty day moving average price of $1.37 and a 200 day moving average price of $1.33. The stock has a market capitalization of $41.15 million, a PE ratio of 74.54 and a beta of 0.59. Covalon Technologies has a 1 year low of $1.16 and a 1 year high of $2.14.
Covalon Technologies Company Profile
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
See Also
- Five stocks we like better than Covalon Technologies
- Corpay’s Quiet Strength Is Winning Wall Street
- Investors Abandoned These 3 AI Stocks Too Early, Says Jeff Clark
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
